Becton Dickinson & Co. Pioneers Breakthroughs in Healthcare

Becton Dickinson & Co., a trailblazing medical technology company, has made a series of groundbreaking announcements that are poised to transform the healthcare landscape. The company has submitted an application to the US FDA for a revolutionary at-home human papillomavirus (HPV) test, which enables patients to self-collect a sample using a swab. This innovative approach simplifies processing at the lab and reports more high-risk strains of HPV than any other test on the market.

This move is a significant step towards empowering women with access and choice for their HPV screening, whether in a doctor’s office or at home. By providing a convenient and user-friendly solution, Becton Dickinson & Co. is addressing a critical need in the healthcare sector and paving the way for improved patient outcomes.

In addition to this breakthrough, the company’s BD Veritor System for SARS-CoV-2 has received FDA 510(k) clearance, allowing for the detection of COVID-19 antigens in symptomatic individuals in about 15 minutes. This rapid diagnostic solution is a game-changer in the fight against COVID-19, enabling healthcare professionals to make informed decisions quickly and effectively.

These developments demonstrate Becton Dickinson & Co.’s unwavering commitment to revolutionizing the medical field through cutting-edge technology and innovation. The company’s dedication to pushing the boundaries of what is possible is a testament to its leadership in the industry and its vision for a healthier future.

Key Highlights:

  • Becton Dickinson & Co. submits application to US FDA for at-home HPV test
  • The test enables patients to self-collect a sample using a swab, simplifying processing at the lab and reporting more high-risk strains of HPV than any other test on the market
  • The company’s BD Veritor System for SARS-CoV-2 receives FDA 510(k) clearance for the detection of COVID-19 antigens in symptomatic individuals in about 15 minutes
  • These developments underscore Becton Dickinson & Co.’s leadership in medical technology and its commitment to innovation and patient care.